Steven R. Schow
2011
In 2011, Steven R. Schow earned a total compensation of $385.4K as Vice President, Research at MabVax Therapeutics Holdings, a 47% increase compared to previous year.
Compensation breakdown
| Option Awards | $123,435 |
|---|---|
| Salary | $262,000 |
| Total | $385,435 |
Schow received $262K in salary, accounting for 68% of the total pay in 2011.
Schow also received $123.4K in option awards.
Rankings
In 2011, Steven R. Schow's compensation ranked 8,781st out of 10,747 executives tracked by ExecPay. In other words, Schow earned more than 18.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,781 out of 10,747 | 18th |
Division Manufacturing | 3,280 out of 3,960 | 17th |
Major group Chemicals And Allied Products | 823 out of 1,033 | 20th |
Industry group Drugs | 606 out of 781 | 22nd |
Industry Pharmaceutical Preparations | 464 out of 571 | 19th |
Source: SEC filing on April 5, 2013.
Schow's colleagues
We found four more compensation records of executives who worked with Steven R. Schow at MabVax Therapeutics Holdings in 2011.
2011
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2011
Marc Steuer
MabVax Therapeutics Holdings
Former Senior Vice President, Business Development
2011
Wendy Wee
MabVax Therapeutics Holdings
Vice President, Finance and Controller
2011
William Kaplan
MabVax Therapeutics Holdings